134 related articles for article (PubMed ID: 38022156)
1. Prediction of Antigenic Vaccine Peptide Candidates From BfmRS Associated With Biofilm Formation in Acinetobacter baumannii.
Girija ASS
Cureus; 2023 Oct; 15(10):e47804. PubMed ID: 38022156
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Putative Epitope Peptides against BaeR Associated with TCS Adaptation in
Girija ASS; Gunasekaran S; Habib S; Aljeldah M; Al Shammari BR; Alshehri AA; Alwashmi ASS; Turkistani SA; Alawfi A; Alshengeti A; Garout M; Alwarthan S; Alsubki RA; Moustafa NM; Rabaan AA
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837545
[No Abstract] [Full Text] [Related]
3. Delineating the Immuno-Dominant Antigenic Vaccine Peptides Against gacS
Smiline Girija AS
Front Microbiol; 2020; 11():2078. PubMed ID: 33013757
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization and epitope-based vaccine predictions for
Sogasu D; Girija ASS; Gunasekaran S; Priyadharsini JV
In Silico Pharmacol; 2021; 9(1):15. PubMed ID: 33520594
[TBL] [Abstract][Full Text] [Related]
5.
Almalki S; Beigh S; Akhter N; Alharbi RA
Saudi J Biol Sci; 2022 Jun; 29(6):103283. PubMed ID: 35574284
[TBL] [Abstract][Full Text] [Related]
6. Predictions of Immunodominant Epitope Peptides From the AsaA Type VI Secretion System in Acinetobacter baumannii: A Computational Approach.
Ranjan M; Girija ASS; Priyadharsini VJ
Cureus; 2024 May; 16(5):e59618. PubMed ID: 38832200
[TBL] [Abstract][Full Text] [Related]
7. Identification of Antigenic Properties of Acinetobacter baumannii Proteins as Novel Putative Vaccine Candidates Using Reverse Vaccinology Approach.
Piri-Gharaghie T; Doosti A; Mirzaei SA
Appl Biochem Biotechnol; 2022 Oct; 194(10):4892-4914. PubMed ID: 35670904
[TBL] [Abstract][Full Text] [Related]
8. Two peptides derivate from Acinetobacter baumannii outer membrane protein K as vaccine candidates: a comprehensive in silico study.
Heidarinia H; Tajbakhsh E; Rostamian M; Momtaz H
BMC Res Notes; 2023 Jun; 16(1):128. PubMed ID: 37391796
[TBL] [Abstract][Full Text] [Related]
9. An In silico Study on B-cell Epitope Mapping of Acinetobacter baumannii Outer Membrane Protein K.
Heidarinia H; Ghadiri K; Zargaran FN; Lorestani RC; Rostamian M
Curr Comput Aided Drug Des; 2024 Jan; ():. PubMed ID: 38288827
[TBL] [Abstract][Full Text] [Related]
10. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.
Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309
[TBL] [Abstract][Full Text] [Related]
11. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
Anand R; Biswal S; Bhatt R; Tiwary BN
PeerJ; 2020; 8():e9855. PubMed ID: 33062414
[TBL] [Abstract][Full Text] [Related]
12. Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach.
Khan NT; Zinnia MA; Islam ABMMK
J Biomol Struct Dyn; 2023 Mar; 41(5):1617-1638. PubMed ID: 34994279
[TBL] [Abstract][Full Text] [Related]
13. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii.
Ahmad S; Azam SS
J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164
[TBL] [Abstract][Full Text] [Related]
14. Multi-epitope DnaK peptide vaccine against S.Typhi: An in silico approach.
Verma S; Sugadev R; Kumar A; Chandna S; Ganju L; Bansal A
Vaccine; 2018 Jun; 36(28):4014-4022. PubMed ID: 29861180
[TBL] [Abstract][Full Text] [Related]
15. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
16. Acinetobacter baumannii Regulates Its Stress Responses via the BfmRS Two-Component Regulatory System.
Palethorpe S; Farrow JM; Wells G; Milton ME; Actis LA; Cavanagh J; Pesci EC
J Bacteriol; 2022 Feb; 204(2):e0049421. PubMed ID: 34871031
[TBL] [Abstract][Full Text] [Related]
17. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Adam KM
Trop Dis Travel Med Vaccines; 2021 Jul; 7(1):22. PubMed ID: 34238372
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatics-guided designing of epitope-based subunit vaccine from Pilus assembly protein of Acinetobacter baumannii bacteria.
Mahapatra SR; Dey J; Jaiswal A; Roy R; Misra N; Suar M
J Immunol Methods; 2022 Sep; 508():113325. PubMed ID: 35908655
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of Acinetobacter nosocomialis BfmRS, two-component regulatory system, essential for biofilm development.
Choi CH; Mun S; Oh MH
Genes Genomics; 2024 May; 46(5):531-539. PubMed ID: 38507111
[TBL] [Abstract][Full Text] [Related]
20. Putative novel B-cell vaccine candidates identified by reverse vaccinology and genomics approaches to control Acinetobacter baumannii serotypes.
Beiranvand S; Doosti A; Mirzaei SA
Infect Genet Evol; 2021 Dec; 96():105138. PubMed ID: 34793968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
